<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. in connection with the IPO of Molecular Partners AG | Pestalozzi Attorneys at Law

Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. in connection with the IPO of Molecular Partners AG

11.2014

Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. as investor in connection with the pre-IPO corporate restructuring steps and the IPO of Molecular Partners AG, a Schlieren based biotech company (SIX: MOLN), which went public on SIX Swiss Exchange in November 2014.

To the top